Fellowship · Charleston, SC
Sponsored by Medical University of South Carolina College of Medicine
Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study.
Journal of the American Academy of Dermatology · 2025 · 19 citations · Lara Lee
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis.
Journal of the American Academy of Dermatology · 2025 · 13 citations · Lara Lee
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.
Advances in therapy · 2024 · 19 citations · Lara Lee
A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis.
Pediatric dermatology · 2024 · 18 citations · Lara Lee
A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies.
Journal of drugs in dermatology : JDD · 2025 · 14 citations · Lara Lee
Dupilumab as treatment of actinic prurigo suggests pathophysiologic mechanism of disease: A case series.
JAAD case reports · 2024 · 4 citations ·
The management of pediatric hidradenitis suppurativa differs between dermatologic and non-dermatologic providers: A retrospective review.
Pediatric dermatology · 2024 · 4 citations · Lara Lee
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years.
Dermatology and therapy · 2023 · 10 citations · Lara Lee